NO176902C - Fremgangsmåte for fremstilling av en doseringsenhet for avgivelse av et aktivt middel - Google Patents

Fremgangsmåte for fremstilling av en doseringsenhet for avgivelse av et aktivt middel

Info

Publication number
NO176902C
NO176902C NO883837A NO883837A NO176902C NO 176902 C NO176902 C NO 176902C NO 883837 A NO883837 A NO 883837A NO 883837 A NO883837 A NO 883837A NO 176902 C NO176902 C NO 176902C
Authority
NO
Norway
Prior art keywords
delivery
preparing
active agent
dosage unit
dosage
Prior art date
Application number
NO883837A
Other languages
English (en)
Other versions
NO883837D0 (no
NO176902B (no
NO883837L (no
Inventor
Maureen L Jordan
Atul Devdatt Ayer
Paul R Magruder
David Emil Edgren
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO883837D0 publication Critical patent/NO883837D0/no
Publication of NO883837L publication Critical patent/NO883837L/no
Publication of NO176902B publication Critical patent/NO176902B/no
Publication of NO176902C publication Critical patent/NO176902C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
NO883837A 1987-09-03 1988-08-29 Fremgangsmåte for fremstilling av en doseringsenhet for avgivelse av et aktivt middel NO176902C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/092,857 US4814181A (en) 1987-09-03 1987-09-03 Dosage form comprising fast agent delivery followed by slow agent delivery

Publications (4)

Publication Number Publication Date
NO883837D0 NO883837D0 (no) 1988-08-29
NO883837L NO883837L (no) 1989-03-06
NO176902B NO176902B (no) 1995-03-13
NO176902C true NO176902C (no) 1995-06-21

Family

ID=22235509

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883837A NO176902C (no) 1987-09-03 1988-08-29 Fremgangsmåte for fremstilling av en doseringsenhet for avgivelse av et aktivt middel

Country Status (23)

Country Link
US (1) US4814181A (no)
JP (1) JPH0196116A (no)
KR (1) KR950006216B1 (no)
AR (1) AR241676A1 (no)
AT (1) AT400296B (no)
AU (1) AU612397B2 (no)
BE (1) BE1001184A3 (no)
CA (1) CA1288016C (no)
CH (1) CH676794A5 (no)
DE (1) DE3829942A1 (no)
DK (1) DK485588A (no)
ES (1) ES2008580A6 (no)
FI (1) FI884056A (no)
FR (1) FR2620025B1 (no)
GB (1) GB2209280B (no)
IE (1) IE61845B1 (no)
IT (1) IT1223798B (no)
LU (1) LU87326A1 (no)
NL (1) NL8802180A (no)
NO (1) NO176902C (no)
PT (1) PT88404B (no)
SE (1) SE8803084L (no)
ZA (1) ZA886435B (no)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366738A (en) * 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US4915953A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering acetaminophen or phenylpropanolamine
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5151093A (en) * 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
US5227167A (en) * 1991-06-11 1993-07-13 Alza Corporation Long-term delivery device including hydrophobic loading dose
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
RU2127586C1 (ru) * 1991-12-27 1999-03-20 Мерк Энд Ко., Инк. Устройство доставки лекарственного препарата, способ получения устройства
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
ES2194210T3 (es) * 1996-08-16 2003-11-16 Alza Corp Forma de dosificacion para suministrar una dosis ascendente de farmaco.
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
JP2004531467A (ja) 2000-11-28 2004-10-14 エフ　エム　シー　コーポレーション 可食性ｐｇａ被覆組成物
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
US8329217B2 (en) * 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
EP1556017A1 (en) * 2002-10-31 2005-07-27 ALZA Corporation Dosage form providing ascending release of liquid formulation
US20040089308A1 (en) * 2002-11-13 2004-05-13 Welch Robert A. Cervical ring to deliver medication
US7332183B2 (en) * 2002-12-26 2008-02-19 Pozen Inc. Multilayer dosage forms containing NSAIDs and triptans
DE602004032149D1 (de) * 2003-09-26 2011-05-19 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
US7897172B2 (en) * 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
WO2007044234A1 (en) * 2005-10-07 2007-04-19 Alza Corporation Osmotic dosage form with controlled release and fast release aspects
BRPI0618687A2 (pt) * 2005-11-18 2011-09-06 Glaxo Group Ltd máquina e método para montagem de produto farmacêutico e produto tipo farmacêutico
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
US20080207593A1 (en) * 2007-02-28 2008-08-28 Collegium Pharmaceutical, Inc. Antihistamine Combination
US8404275B2 (en) * 2007-07-01 2013-03-26 Vitalis Llc Combination tablet with chewable outer layer
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
SG175388A1 (en) 2009-04-28 2011-12-29 Proteus Biomedical Inc Highly reliable ingestible event markers and methods for using the same
UA109424C2 (uk) * 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
BR112012025650A2 (pt) 2010-04-07 2020-08-18 Proteus Digital Health, Inc. dispositivo ingerível miniatura
WO2012071280A2 (en) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Ingestible device with pharmaceutical product
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2013063078A1 (en) 2011-10-28 2013-05-02 Vitalis Llc Anti-flush compositions
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
CN111493872B (zh) 2016-07-22 2023-05-05 大冢制药株式会社 可摄入事件标记的电磁感测和检测
CN109963499B (zh) 2016-10-26 2022-02-25 大冢制药株式会社 用于制造具有可吸收事件标记器的胶囊的方法
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
KR20180071226A (ko) 2018-06-12 2018-06-27 김성규 관성을 이용한 자동차 연료 절약 장치
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569482A5 (no) * 1970-12-23 1975-11-28 Boehringer Sohn Ingelheim
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4475916A (en) * 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
DK90883A (da) * 1982-03-18 1983-09-19 Merck & Co Inc Beholder til osmotisk afgivelse af et stof eller en stofblanding
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4673405A (en) * 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
GB2189702B (en) * 1986-04-30 1989-10-18 Alza Corp Dosage form with improved delivery capability
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing

Also Published As

Publication number Publication date
NL8802180A (nl) 1989-04-03
CA1288016C (en) 1991-08-27
NO883837D0 (no) 1988-08-29
SE8803084L (sv) 1989-03-04
FR2620025A1 (fr) 1989-03-10
GB2209280A (en) 1989-05-10
SE8803084D0 (sv) 1988-09-02
NO176902B (no) 1995-03-13
AU2152688A (en) 1989-03-09
US4814181A (en) 1989-03-21
IT1223798B (it) 1990-09-29
DK485588D0 (da) 1988-09-01
LU87326A1 (fr) 1989-03-08
ATA214488A (de) 1995-04-15
DE3829942A1 (de) 1989-03-16
IT8867790A0 (it) 1988-09-02
GB8820460D0 (en) 1988-09-28
GB2209280B (en) 1991-09-04
BE1001184A3 (fr) 1989-08-08
IE61845B1 (en) 1994-11-30
AR241676A1 (es) 1992-10-30
KR950006216B1 (ko) 1995-06-12
PT88404A (pt) 1989-07-31
FI884056A (fi) 1989-03-04
IE882641L (en) 1989-03-03
JPH0196116A (ja) 1989-04-14
ZA886435B (en) 1989-05-30
DK485588A (da) 1989-03-04
AU612397B2 (en) 1991-07-11
AT400296B (de) 1995-11-27
CH676794A5 (no) 1991-03-15
ES2008580A6 (es) 1989-07-16
PT88404B (pt) 1993-02-26
NO883837L (no) 1989-03-06
FR2620025B1 (fr) 1990-04-20
FI884056A0 (fi) 1988-09-02
KR890004684A (ko) 1989-05-09

Similar Documents

Publication Publication Date Title
NO176902C (no) Fremgangsmåte for fremstilling av en doseringsenhet for avgivelse av et aktivt middel
NO176466C (no) Fremgangsmåte til fremstilling av doseringsenhet for avgivelse av et aktivt middel til et bruksmiljö
NO178564C (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
AU570506B2 (en) Intra-pocket drug delivery devices for treatment of periodontal diseases
NO883667L (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
FI901787A0 (fi) Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
NO177038C (no) Fremgangsmåte for fremstilling av et farmasöytisk doseringssystem
HUT51617A (en) Process for producing oxadiazole derivatives and pharmaceutical preparations containing these compounds as active substance
IL65080A (en) Bandage for administering beneficial drug
FI885884A0 (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
HUT41630A (en) Process for producing retarde granulated products of pharmaceutical active agents
HUT41642A (en) Process for producing tablets of regulated dissolution of the active agents
FI881223A (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen 9-aminotetrahydroakriinien ja niille läheisten yhdisteiden valmistamiseksi
FI880869A (fi) Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
NO176273C (no) Analogifremgangsmåte for fremstilling av aktive substituerte benzamider
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI884471A0 (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NZ196288A (en) Pharmaceutical active substance administration
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
IT8448983A0 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI100799B (fi) Menetelmä terapeuttisesti aktiivisten tetraliinijohdannaisten valmista miseksi